Philip D. Harvey, Ph.D.

Philip D. Harvey received his Ph.D. in Clinical Psychology from SUNY at Stony Brook in 1982.  He is the author of over 800 scientific papers and abstracts and he has written over 30 book chapters.  He is a widely cited author whose work has been cited more than 500 times per year for the past decade, with over 1,500 citations of his work in 2009 alone.  He has given more than 1,500 presentations at scientific conferences and medical education events.  His clinical activities and research has focused for years on cognition and functioning and he has written extensively on aging in schizophrenia, functional impairments in the illness, the cognitive effects of typical and atypical antipsychotics, as well as studying the effects of cognitive enhancing agents in various conditions, including schizophrenia, dementia, and traumatic brain injury.  He directs a biennial conference on cognition that is an official satellite of the International Congress on Schizophrenia Research. 

Dr. Harvey has edited five books and written four books on topics of psychological assessment, schizophrenia, and aging.  He is a  member of the American Psychological Association, the American College of Neuropsychopharmacology (Fellow), the Collegium Internationale Neuropharmacologium (Fellow), the Society for Research in Psychopathology (Founding Member), the Society for Biological Psychiatry, the International Neuropsychological Society, the Schizophrenia International Research Society (Founding Director), and the International Society for Clinical Trials and Methodology (Founding Member).

FORMAL CV 

Ph.D.        1982, Major: Clinical Psychology
                 State University of New York at Stony Brook

M.A.         1980, Major:  Clinical Psychology
                  State University of New York at Stony Brook

B.A.           1978, Major: Psychology
                   Columbia College, New York, NY

Licensure:  Florida Psychology License, September 16, 2010.

Dr. Harvey's clinical interests include aging and dementia; as well as cognition and disability in adults and older individuals. His clinical activities and research has focused for years on cognition and functioning and he has written extensively on aging in schizophrenia, functional impairments in the illness, the cognitive effects of typical and atypical antipsychotics, as well as studying the effects of cognitive enhancing agents in various conditions, including schizophrenia, dementia, and traumatic brain injury. 

Dr. Harvey's research interests include cognition and everyday functioning with a focus on severe mental illness.  He is also interested in functioning in other neuropsychiatric conditions including traumatic brain injury, dementia, and Parkinson's Disease.

BOOKS

1. Philip D. Harvey & Elaine Walker (Eds.) Positive and Negative Symptoms in Psychosis: Description, Research, and Future Directions. Hillsdale, NJ: Erlbaum, 1987.

2. Rebecca A. Prussin & Philip D. Harvey. Hooked on exercise: A guide to the identification and treatment of exercise addiction. New York: Simon and Schuster, 1992. Reissued by Gur Publishers, Inc, 1995.

3. Richard S.E. Keefe & Philip D. Harvey. Understanding Schizophrenia. New York: Free Press, 1994.

4. Philip D. Harvey (Ed.). Optimizing cognitive function in patients with schizophrenia. London: Gardner Caldwell Communications, 1998.

5. Tonmoy Sharma & Philip D. Harvey (Eds.). Cognitive functioning in schizophrenia: Characteristics, Correlates, and Treatment Strategies. Oxford: Oxford University Press, 2000

6. Philip D. Harvey & Tonmoy Sharma. Understanding and treating Cognition in schizophrenia: A clinician's handbook. London, Martin Dunitz, 2001. Re-issued in Chinese, Japanese, Italian, and French (2003-2007).

7. Philip D. Harvey. Schizophrenia in late life. Washington, DC, American Psychological Association Press, 2004.

8. Tonmoy Sharma & Philip D. Harvey. (Eds.). The early course of schizophrenia, Oxford (UK), 2006.

BOOK CHAPTERS (Selected):

1. Rachel Yehuda, Julia A. Golier, & Philip D. Harvey. Learning and memory in aging trauma survivors with PTSD In. Vasterling and Brewin, (eds). Pp. 208-230. Neuropsychology of PTSD. Guilford Press: New York, 2005.

2. Christopher R. Bowie & Philip D. Harvey. Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatric Clinics of North America, 2005 28, 613-633.

3. Philip D. Harvey. Late onset schizophrenia.. In Tonmoy Sharma & Philip D. Harvey. Pp. 175-188. The early course of schizophrenia, Oxford (UK), 2006.

4. Richard SE Keefe & Philip D. Harvey. Schizophrenia. In the McGraw-Hill Encyclopedia of Science and Technology. New York: McGraw Hill 2006.

5. Philip D. Harvey. Cognitive deficits as a core feature of schizophrenia. In CG Kruse, HY Meltzer, C Sennef, and SV van de Witte (Eds.). Thinking about cognition: Concepts, targets, and therapeutics. Pp. 29-38. Amsterdam: IOS Press, 2007

6. Jean-Pierre Lindenmeyer, Philip D. Harvey, Anzalee Kahn, & Brian Kirkpatrick. Schizophrenia: Assessment of Psychopathology.Psychiatric Clinics of North America, 2007, 30, 339-363.

7. Philip D. Harvey. Recent developments in the treatment of cognitive impairments and negative symptoms in schizophrenia. In Gunvant K. Thaker and William T. Carpenter (Eds.). The Year in Schizophrenia. Volume 2. Clinical Publishing, Oxford, 2008, pp. 217-222.

8. Philip D. Harvey and Christopher R. Bowie. The clinical neuropsychology of schizophrenia. In MG Gelder, JJLopez-Ibor and Nancy C. Andreasen (eds.). New Oxford Comprehensive Textbook of Psychiatry (2 ed). Pp. 1275-1290. Oxford University Press: Oxford, 2009

9. Philip D. Harvey and Richard S.E. Keefe. Clinical neuropsychology of schizophrenia. In I Grant and K.M. Adams (Eds.).Neuropsychological Assessment of Neuropsychiatric and Neuromedical Disorders, 3^rd Edition. Oxford University Press, NY, 2009, pp 507-522.

10. Philip D. Harvey. Disability in Schizophrenia. In IB Wiener and WE Craighead (Eds.). Corsini's Encyclopedia of Psychology. 4^th edition. Pp. 481-483John Wiley: New York, 2010.

11. Michael Compton & Philip D. Harvey. Risk factors for the development of schizophrenia during adulthood. In R Ingram and J Price (Eds.). Vulnerablity to psychopathology, second edition. pp. 389-416. New York: Guilford, 2010

12. Patricia A. Brennan & Philip D. Harvey Vulnerability to Schizophrenia: Integration and further examination. In R Ingram and J Price (Eds.). Vulnerablity to psychopathology, second edition. pp. 417-424. New York: Guilford, 2010.

13. Philip D. Harvey. Cognitive impairment in schizophrenia. In TL Schlaepfer and CB Nemeroff (eds.). Neurobiology of Psychiatric Diseases. London: Oxford, in press.

14. Adrian Preda, Robert G. Bota, Philip D. Harvey. Neurocognitive Deficits, Negative Symptoms, and Insight in Schizophrenia. In M Ritsner (ed). Textbook of Schizophrenia Spectrum Disorders. New York: Springer-Verlag, in press.

ARTICLES IN REFEREED JOURNALS (Selected):

1. Philip D. Harvey, Howard Hassman, Lian Mao, Georges W. Gharabawai, Ramy Mahmoud, & Luella Englehart. Cognitive functioning and the acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: A randomized double-blind cross-over study. Journal of Clinical Psychiatry, 2007, 68, 1186-1194.

2. Philip D. Harvey. Outcomes to Monitor When Treating Bipolar Disorder or Schizophrenia. Journal of Clinical Psychiatry. 2006;67:e06.

3.Philip D. Harvey. Cognitive and functional effects of atypical antipsychotic medications. Journal of Clinical Psychiatry. 2006;67:e13.

4. Peter F. Buckley, Philip D. Harvey, Christopher R. Bowie, & Antony Loebel. The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone Schizophrenia Research, 2007, 61, 896-902.

5. Philip D. Harvey, Alan S. Bellack, & Dawn Velligan. Performance-Based Measures of Functional Skills: Usefulness in Clinical Treatment Studies. Schizophrenia Bulletin, 2007, 33, 1138-1148

6. Margaret M. McClure and Philip D. Harvey. Critical Issues in the Assessment of Disability in Schizophrenia. Journal of Clinical Schizophrenia and Related Psychoses, 2007, 1, 18-27.

7. Philip D. Harvey. Cognition and the Differential Diagnosis of schizophrenia. World Psychiatry, 2008, 7 30-32.

8. Philip D. Harvey, Emilio Sacchetti, Alessandro Galluzzo, Fabio Romeo, Barbara Gorini, Robert M. Bilder, Antony Loebel. A Randomized Double-Blind Comparison of Ziprasidone vs. Clozapine for Cognition in Patients with Schizophrenia Selected for Resistance or Intolerance to Previous Treatment. Schizophrenia Research, 2008, 105, 138-143.

9. Philip D. Harvey. Managing cognitive deficits and functioning in patients with schizophrenia. Journal of Clinical Psychiatry, 2007, 68, e21.

10. Philip D. Harvey. The Broad Importance of Cognitive impairments in Aging-Related Disorders. American Journal of Geriatric Psychiatry, 2008, 16, 99-101..

11. Philip D. Harvey & Barbara A. Cornblatt. Pharmacological Treatment of Cognition in Schizophrenia: An Idea whose Method has Come. American Journal of Psychiatry, 2008, 165:163-165.

12. Richard SE Keefe, Philip D. Harvey, Terry E. Goldberg, James M. Gold, Trina M. Walker, Courtney Kennel, Kirsten Hawkins. Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS). Schizophrenia Research, 2008, 102, 108-115.

13. Rachel Yehuda, Philip D. Harvey, Julia Golier, Randall E. Newmark, Christopher R. Bowie, Janelle J. Wohltmann, Robert A. Grossman, James Schmeidler, Erin A. Hazlett, Monte S. Buchsbaum, ¹⁸FDG-PET response to cortisol in aging veterans with post-traumatic stress disorder Journal of Neuropsychiatry and Clinical Neurosciences, 2009, 21,132-143.

14. Abraham Reichenberg, Philip D. Harvey, Christopher R. Bowie, Ramin Mojtabai, Jonathon Rabinowitz , Robert K Heaton, Evelyn Bromet. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophrenia Bulletin, 2009, 35, 1022-1029

15. Richard SE Keefe & Philip D. Harvey. Implementation Considerations for Multi-site Clinical Trials with Cognitive Neuroscience Tasks Schizophrenia Bulletin, 2008, 34: 656-663

16. Philip D. Harvey, Richard SE Keefe, Thomas L. Patterson, Robert K. Heaton, Christopher R. Bowie. Abbreviated neuropsychological assessments in schizophrenia: Association with different outcomes measures.Journal of Clinical and Experimental Neuropsychology, 2009,31,462-471.

17. Christopher R. Bowie & Philip D. Harvey. Communication Disorder is a Predictor of Functional Disability in Older Patients with Chronic Schizophrenia: Differential Associations with Social and Adaptive Functions Schizophrenia Research, 2008, 103:240-247.

18. Aliza Wingo, Philip D. Harvey, & Ross Baldessarini. Cognitive impairment in euthymic bipolar patients: Functional implications. Bipolar Disorders, 2009, 11,113-125.

19. Philip D. Harvey, Jean M. Endicott, & Antony Loebel. Factor structure in mixed and manic episodes prior to and after antipsychotic treatment.Bipolar Disorders, 10, 2009, 900-906.

20. Thomas L. Patterson & Philip D. Harvey. Real-World Functioning and Self-Evaluation of Functioning: Brain Structure, Mood State, Functional Skills, and Mortality. International Journal of Geriatric Psychiatry, 2008, 16, 617-620.

21. Philip D. Harvey, David L. Pogge, Kevin Young. Factor structure of clinical symptoms in depressed inpatients with unipolar and bipolar affective disorders. Journal of Nervous and Mental Disease, 2009, 197, 161-165

22. Dwight Dickinson & Philip D. Harvey. Systemic hypotheses for generalized cognitive deficits in schizophrenia: A new take on an old problem. Schizophrenia Bulletin, 2009, 35, 403-414.

23. Philip D. Harvey & Roberto Cavallaro. Meeting Report: The Emory University-San Rafaelle Satellite Meeting on Cognition in Schizophrenia. Schizophrenia Research, 113, 347-350.

24. Philip D. Harvey & Alan S. Bellack. Toward a terminology of functional recovery in schizophrenia: Is functional remission a viable concept? Schizophrenia Bulletin, 2009, 35, 300-306.

25. Philip D. Harvey, Steven H. Ferris, Jeffrey L. Cummings, Keith A. Wesnes, Jay Hsu, Roger M. Lane, Sibel Tekin. Evaluation of Dementia Rating Scales in Parkinson's Disease Dementia. American Journal of Alzheimer's Disease and Other Dementias, 2010,25, 142-148

26. Philip D. Harvey. Pharmacological cognitive enhancement in schizophrenia. Neuropsychology Review, 2009, 19, 324-35.

27. Philip D. Harvey, Elizabeth Pappadopolus, Ilise Lombardo, & Charlotte M. Kremer. Reduction of Functional Disability with Atypical Antipsychotic Treatment: A Randomized Long Term Comparison of Ziprasidone and Haloperidol. Schizophrenia Research, 2009, 115, 24-29.

28. Philip D. Harvey, Lars Helldin, Christopher R. Bowie, Robert K. Heaton, Anna-Karin Olsson, Fredrik Hjärthag, Torsten Norlander, & Thomas L. Patterson.. Performance-Based Measurement of Functional Disability in Schizophrenia: A cross-national Study in the United States and Sweden. American Journal of Psychiatry, 2009, 166, 821-827.

29. Philip D. Harvey. Functional Recovery in Schizophrenia: Raising the Bar for Outcomes in People with Schizophrenia. Schizophrenia Bulletin, 2009, 35, 299.

30. Philip D. Harvey. Genetics of cognitive impairment in schizophrenia. Psychiatry (Edgemont), 2008, 5 :65-67

31. Philip D. Harvey. CNTRICS: Bringing Clinical Treatment Trials Closer to the Brain. Psychiatry (Edgemont), 2008, 5, 57-58.

32. Philip D. Harvey When does cognitive decline occur in the period prior to the first episode of schizophrenia?Psychiatry (Edgemont), 2009, 6, 12-14.

33. Philip D. Harvey Is it possible to assess cognitive impairment other than with neuropsychological tests? Psychiatry (Edgemont), 2009, 6, 23-25.

34. Philip D. Harvey, Abraham Reichenberg, Christopher R. Bowie, Thomas L. Patterson, & Robert K. Heaton. The course of Neuropsychological Performance and Functional Capacity in Older Patients with Schizophrenia: Influences of Previous history of long-term institutional Stay. Biological Psychiatry, 2010,67, 933-939.

35. Philip D. Harvey, Aliza P. Wingo, Katherine E. Burdick, & Ross J. Baldessarini. Cognition and Disability in Bipolar Disorder: Lessons from Schizophrenia Research. Bipolar Disorders, 2010, 12, 364-375

36. Philip D. Harvey & David L Penn. Social cognition: The key factor predicting social outcome in people with schizophrenia? Psychiatry (Edgemont), 2010,7, 41-44.

37. Philip D. Harvey, Michael F. Green, & Keith Nuechterlein. The latest developments in the MATRICS process. Psychiatry (Edgmont). 2010, 7, 49-52.